PAI-1 secretion and matrix deposition in human peritoneal mesothelial cell cultures: Transcriptional regulation by TGF-β1

Kidney International

Volumn 54, Issue 1, 1998, Pages 87-98

  Rougier, Jean Philippe ^a   Guia, Sophie ^b   Hagège, Jacqueline ^b   Nguyen, Geneviève ^b   Ronco, Pierre M ^b  

^a HÔPITAL TENON   (France)

^b NONE

Author keywords

Fibrin; Fibrosis; Injury repair; Mesothelial cells; Peritoneal dialysis; Plasmin; Plasminogen activator inhibitor 1; Ultrafiltration

Indexed keywords

GELATINASE B; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL CULTURE; CELL MIGRATION; EXTRACELLULAR MATRIX; FIBRINOLYSIS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MESOTHELIUM CELL; NORTHERN BLOTTING; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN SYNTHESIS; TRANSCRIPTION REGULATION;

EID: 0031832892     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00955.x     Document Type: Article

References (50)

1. DOBBIE JW: Ultrastructure and pathology of the peritoneum in peritoneal dialysis, in The Textbook of Peritoneal Dialysis, edited by GOKAL R, NOLPH KD, Dordrecht, Kluwer Academic Publishers, 1994, pp 17-44
2. LIOTTA LA, GOLDFARB RH, BRUNDAGE R, SIEGAL GP, TERRANOVA V, GARBISA S: Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane. Cancer Res 41:4629-4636, 1981
3. MIGNATTI P, RIFKIN DB: Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 73:161-195, 1993
4. PLOW EF, HERREN T, REDLITZ A, MILES LA, HOOVER-PLOW JL: The cell biology of the plasminogen system. FASEB J 9:939-945, 1995
5. KRUITHOF EKO: Plasminogen activator inhibitors: A review. Enzyme 40:113-121, 1988
6. VAN HINSBERGH VWM, KOOISTRA T, SCHEFFER A, VAN BOCKEL JH, VAN MUIJEN GNP: Characterization and fibrinolytic properties of human omental tissue mesothelial cells: comparison with endothelial cells. Blood 75:14911-1497, 1990
7. RONDEAU E, SRAER JD, SCHLEUNING WD: The renal plasminogen activating system, in Molecular Nephrology: Kidney Function in Health and Disease, edited by SCHLONDORFF D, BONVENTRE JV, New York, Marcel Decker Inc., 1995, pp 699-715
8. SAWDEY MS, LOSKUTTOFF DJ: Regulation of murine type 1 plasminogen activator inhibitor gone expression in vivo. J Clin Invest 88:1346-1353, 1991
9. HARVEY W, AMLOT PL: Collagen production by mesothelial cells in vitro. J Pathol 139:337-347, 1983
10. RENNARD SI, JAURAND M-C, BIGNON J, KAWANAMI O, FERRANS VJ, DAIDSON J, CRYSTAL RG: Role of pleural mesothelial cells in the production of the submesothelial connective tissue matrix of lung. Am Rev Resp Dis 130:267-274, 1984
11. IDELL S, ZWIEB C, KUMAR A, KOENIG KB, JOHNSON AR: Pathways of fibrin turnover of human pleural mesothelial cells in vitro. Am J Respir Cell Mol Biol 7:414-426, 1992
12. TOPLEY M, JÖRRES A, LUTTMANN W, PETERSEN MM, LANG MJ, THIERAUCH KH, MÜLLER C, COLES GA, DAVIES M, WILLIAMS JD: Human peritoneal cells synthesize interleukin-6 (IL-6): Induction by IL-1β and TNFα. Kidney Int 43:226-233, 1993
13. OFFNER FA, FEICHTINGER H, STADLMANN S, OBRIST P, MARTH C, KLINGER P, GRAGE B, SCHMAHL M, KNAHBBE C: Transforming growth factor-β synthesis by human peritoneal mesothelial cells. Am J Pathol 148:1679-1688, 1996
14. ROBERTS AB, MCCUNE BK, SPORN MB: TGF-β: Regulation of extracellular matrix. Kidney Int 41:557-559, 1992
15. OVERALL CM, WRANA JL, SODEK J: Independent regulation of collagenase, 72 kD progelatinase and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-β. J Biol Chem 264:1860-1869, 1989
16. MARTI HP, LEE L, KASHGARIAN M, LOVETT DH: Transforming growth factor-β1 stimulates glomerular mesangial cell synthesis of the 72-KD type IV collagenase. Am J Pathol 144:82-94, 1994
17. SALO T, LYONS JG, RAHEMTULLA F, BIRKEDAL-HANSEN H, LARJAVA H: Transforming growth factor-β up-regulates type IV collagenase expression in cultured human keratinocytes. J Biol Chem 266:11436-11441, 1991
18. ROUGIER J-PH, MOULLIER PH, PIEDAGNEL R, RONCO PM: Hyperosmolality suppresses but TGF-β1 increases MMP9 in human peritoneal mesothelial cells. Kidney Int 51:337-347, 1997
19. STEFANSSON S, LAWRENCE DA: The serpin PAI-1 inhibits cell migration by blocking integrin αvβ3 binding to vitronectin. Science 383:441-443, 1996
20. DENG G, CURRIDEN SA, WANG S, ROSENBERG S, LOSKUTOFF DJ: Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release. J Cell Biol 134:1563-1571, 1996
21. WALTZ DA, NATKIN LR, FUJITA RM, WEI Y, CHAPMAN HA: Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin. J Clin Invest 100:58-67, 1997
22. PETZELBAUER E, SPRINGHORN JP, TUCKER AM, MADRI JA: Role of plasminogen activator inhibitor in the reciprocal regulation of bovine aortic endothelial and smooth muscle cell migration by TGF-β1. Am J Pathol 149:923-931, 1996
23. STYLIANOU E, JENNER LA, DAVIES M, COLES GA, WILLIAMS JD: Isolation, culture and characterization of human peritoneal mesothelial cells. Kidney Int 37:1563-1570, 1990
24. GRANELLI-PIPERNO A, REICH E: A study of proteases and protease-inhibitor complexes in biological fluids. J Exp Med 148:223-224, 1978
25. RONDEAU E, OCHI S, LACAVE R, HE CJ, MEDCALF R, DELARUE F, SRAER JD: Urokinase synthesis and binding by glomerular epithelial cells in culture. Kidney Int 36:593-600, 1989
26. RANBY M, NORMAN B, WALLEN P: A sensitive assay for tissue plasminogen activator. Thromb Res 27:743-748, 1982
27. CHOMCZYNSKI P, SACCHI N: Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroforme extraction. Anal Biochem 162:156-159, 1987
28. GREENBERG ME, ZIFF EB: Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature 311:433-488, 1984
29. PIEDAGNEL R, PRIE D, CASSINGENA R, RONCO PM, LELONGT B: SV40 large-T oncogene inhibits transcription of perlecan-related proteoglycans but stimulates hyaluronan synthesis in a temperature-sensitive renal-tubule principal cell line. J Biol Chem 269:17464-76, 1994
30. HAGEGE J, PERALDI MN, RONDEAU E, ADIDA C, DELARUF F, MEDCALF R, SCHLEUNING WD, SRAER JD: Plasminogen activator inhibitor-1 deposition in the extracellular matrix of cultured human mesangial cells. Am J Pathol 141:117-128, 1992
31. KOSAKA T, NAGATSU I, WU J-Y, HAMA K: Use of high concentrations of glutaraldehyde for immunocytochemistry of transmitter-synthesizing enzymes in the central nervous system. Neuroscience 18:975-990. 1986
32. NY T, SAWDEY M, LAWRENCE D, MILLAN JL, LOSKUTOFF DJ: Cloning and sequence of a cDNA coding for the human β-migrating endothelial-cell-type plasminogen activator inhibitor. Proc Nat Acad Sci USA 83:6776-6780, 1986
33. FATTAL PG, BILLADELLO JJ: Species-specific differential cleavage and polyadenylation of plasminogen activator inhibitor type 1 mRNA. Nucleic Acids Res 21:1463-1466, 1993
34. BOSMA PJ, KOOISTRA T: Different induction of two plasminogen activator inhibitor 1 mRNA species by phorbol ester in human hepatoma cells. J Biol Chem 266:17845-17849, 1991
35. RHEINWALD JG, JORGENSEN JL, HAHN WC, TERPSTRA AJ, O'CONNELL TM, PLUMMER K: Mesosecrin, a secreted glycoprotein produced in abundance by human mesothelium and mesothelioma in vivo and in culture. J Cell Biol 104:263-275, 1987
36. CICILA GT, O'CONNELL TM, HAHN WC, RHEINWALD JG: Cloned cDNA sequence for the human mesothelial protein 'mesosecrin' discloses its identity as a plasminogen activator inhibitor (PAI-1) and a recent evolutionary change in transcript processing. J Cell Sci 94:1-10, 1989
37. LOSKUTOFF DJ, LINDERS M, KEIJER J, VEERMAN H, VAN HEFRIKHUIZEN H, PANNEKOEK H: Structure of the human plasminogen activator inhibitor gene: Non random distribution of introns. Biochemistry 26:3763-3768, 1987
38. PENTTINEN RS, KOBAYASHI S, BORNSTEIN P: Transforming growth factor β increases mRNA for matrix proteins both in the presence and in the absence of changes in mRNA stability. Proc Natl Acad Sci USA 85:1105-1108, 1988
39. SEIFFERT D, MIMURO J, SCHLEEF RR, LOSKUTOFF DJ: Interactions between type 1 plasminonen activator inhibitor, extracellular matrix and vitronectin. Cell Differ Dev 32:287-292, 1990
40. BOYLAN AM, SANAN DA, SHEPPARD D, BROADDUS VC: Vitronectin enhances internalization of crocidolite asbestos by rabbit pleural mesothelial cells via the integrin alpha v beta 5. J Clin Invest 96:1987-2001, 1995
41. SITTER T, TOET K, FRICKE H, SCHIFFL H, HELD E, KOOISTRA T: Modulation of procoagulant and fibrinolytic system components of mesothelial cells by inflammatory mediators. Am J Physiol 271:R1256-R1263, 1996
42. ZEMEL D, KOOMEN GCM, HARI AAM, TEN BERGE IGM, STRUIJK DG, KREDIET RT: Relationship of TNFalpha, interleukin 6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis. J Lab Clin Med 122:686-696, 1993
43. EITZMAN DT, MCCOY RD, ZHENG X, FAY WP, SHEN T, GINSBURG D, SIMON RH: Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. J Clin Invest 97:232-237, 1996
44. BARAZZONE C, BELIN D, PIGUET PF, VASSALI JD, SAPPINO AP: Plasminogen activator inhibitor-1 in acute hyperoxic mouse lung injury. J Clin Invest 98:2666-2673, 1996
45. KITCHING AR, HOLDSWORTH SR, PLOPIS VA, PLOW EF, COLLEN D, CARMELIET P, TIPPING PG: Plasminogen and plasminogen activators protect against renal injury in crescentic glomerulonephritis. J Exp Med 185:963-968, 1997
46. RONDEAU E, MOUGENOT B, LACAVE R, PERALDI MN, KRUITHOF EKO, SRAER JD: Plasminogen activator inhibitor 1 in renal fibrin deposits of human nephropathies. Clin Nephrol 33:55-60, 1990
47. BERTOZZI P, ASTEDT B, ZENZIUS L, LYNCH K, LEMAIRE F, ZAPOL W, CHAPMAN HJ: Depressed broncoalveolar urokinase activity in patients with adult respiratory distress syndrome. N Engl J Med 322:890-897, 1990
48. IDELL S, JAMES KK, LEVIN EG, SCHWARTZ BS, MANCHADA N, MAUNDER RJ, MARTIN TR, MCLARTY J, FAIR DS: Local abnormalities in coagulation and tibrinolytie pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome. J Clin Invest 84:695-705, 1989
49. TUAN TL, ZHU JY, SUN B, NICHTER LS, NIMNI ME, LAUG WE: Elevated levels of plasminogen activator inhibitor-1 may account for the altered fibrinolysis by keloid fibroblasts. J Invest Dermatol 106: 1007-1011, 1996
50. LIN JJ, SINGHAL K, PARTON L, CASCIO C, PATLAK CS, STEWART CL: Correlations between plasminogen activator inhibitor-1 and peritoneal transport in pediatric CCPD patients. Perit Dial Int 15:246-251, 1995